Modelling the potential impact of population-wide periconceptional folate/multivitamin supplementation on multiple births

Authors: Lumley, Judith1; Watson, Lyndsey1; Watson, Max2; Bower, Carol3

Source: BJOG: An International Journal of Obstetrics & Gynaecology, Volume 108, Number 9, September 2001 , pp. 937-942(6)

Publisher: Blackwell Publishing

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

Abstract:

Objective

To develop a model of the impact of population-wide periconceptional folate supplementation on neural tube defects and twin births. Design

A hypothetical cohort of 100,000 pregnancies ≥20 weeks, plus terminations of pregnancy after prenatal diagnosis before 20 weeks. Methods

Application of pooled data on the relative risks for neural tube defects and twins following periconceptional folate from meta-analysis of the randomised trials. Main outcome measures

1. Pregnancies with a neural tube defect (i.e. terminations of pregnancy, perinatal deaths, and surviving infants); 2. twin births (i.e. preterm births, perinatal deaths, postneonatal deaths, birth defects, cerebral palsy); 3. numbers needed to treat. Results

The change in neural tube defects would be 75 fewer terminations (95% CI -47, -90), 30 fewer perinatal deaths (95% CI 18, -35), and 13 fewer surviving infants with a neural tube defect (95% CI -8, -16). The change in twinning would be an additional 572 twin confinements (95% CI -100, +1587), among whom there would be 63 very preterm twin confinements (95% CI -11, +174), 54 perinatal and postneonatal deaths (95% CI -9, +149), 48 surviving twins with a birth defect (95% CI -8, +133), and nine with cerebral palsy (95% CI -2, +26). The numbers needed to treat for the prevention of one pregnancy with a neural tube defect is 847, for the birth of one additional set of twins is 175, for the birth of one additional set of very preterm twins is 1587, and for the birth of an additional twin with any of the following outcomes (perinatal death, postneonatal death, survival with a birth defect, or survival with cerebral palsy) is 901. Conclusions

Monitoring rates of neural tube defects and twinning is essential as supplementation or fortification with folate is implemented.

Document Type: Research article

DOI: 10.1111/j.1471-0528.2001.00228.x

Affiliations: 1: Centre for the Study of Mothers' and Children's Health, La Trobe University, Melbourne, Australia 2: Department of Perinatal Medicine, Royal Women's Hospital, Melbourne, Australia 3: TVW Telethon Institute for Child Health Research, Perth, Western Australia, Australia

The full text electronic article is available for purchase. You will be able to download the full text electronic article after payment.

$50.16 plus tax      Refund Policy

 

OR

Back to top

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A